Marie, S.; Hernández-Lozano, I.; Breuil, L.; Saba, W.; Novell, A.; Gennisson, J.-L.; Langer, O.; Truillet, C.; Tournier, N.
Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [99mTc]mebrofenin Imaging in Rats. Pharmaceutics 2020, 12, 486.
https://doi.org/10.3390/pharmaceutics12060486
AMA Style
Marie S, Hernández-Lozano I, Breuil L, Saba W, Novell A, Gennisson J-L, Langer O, Truillet C, Tournier N.
Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [99mTc]mebrofenin Imaging in Rats. Pharmaceutics. 2020; 12(6):486.
https://doi.org/10.3390/pharmaceutics12060486
Chicago/Turabian Style
Marie, Solène, Irene Hernández-Lozano, Louise Breuil, Wadad Saba, Anthony Novell, Jean-Luc Gennisson, Oliver Langer, Charles Truillet, and Nicolas Tournier.
2020. "Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [99mTc]mebrofenin Imaging in Rats" Pharmaceutics 12, no. 6: 486.
https://doi.org/10.3390/pharmaceutics12060486
APA Style
Marie, S., Hernández-Lozano, I., Breuil, L., Saba, W., Novell, A., Gennisson, J.-L., Langer, O., Truillet, C., & Tournier, N.
(2020). Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [99mTc]mebrofenin Imaging in Rats. Pharmaceutics, 12(6), 486.
https://doi.org/10.3390/pharmaceutics12060486